Our Products

At LEO Pharma, we are dedicated to developing drugs and therapies that deliver unique value to patients and societies all around the world. Within the United States, below represents our currently available products. 

Please note the product information on this site is intended for U.S. residents only, and product labeling may vary from labeling in different countries.

   

Desonate® (desonide) Gel, 0.05%

www.desonate.com

Desonate® (desonide) Gel, 0.05% Prescribing Information

   

Dovonex® (calcipotriene) Cream, 0.005%

Dovonex® (calcipotriene) Cream, 0.005% Prescribing Information

   

Enstilar® (calcipotriene and betamethasone dipropionate) Foam, 0.005%/0.064%

enstilar.com

Enstilar® (calcipotriene and betamethasone dipropionate) Foam, 0.005%/0.064% Prescribing Information 

   

Finacea® (azelaic acid) Foam, 15%

www.finaceafoam.com

Finacea® (azelaic acid) Foam, 15% Prescribing Information

   

Finacea® (azelaic acid) Gel, 15%

Finacea® (azelaic acid) Gel, 15% Prescribing Information

   

Picato® (ingenol mebutate) Gel, 0.015% and 0.05%

www.picato.com

Picato® (ingenol mebutate) Gel, 0.015% and 0.05% Prescribing Information



   

Protopic® (tacrolimus) Ointment, 0.03% and 0.1%

Protopic® (tacrolimus) Ointment, 0.03% and 0.1% Prescribing Information, including BOXED WARNING

 

   

Taclonex® (calcipotriene and betamethasone dipropionate) Ointment

Taclonex® (calcipotriene and betamethasone dipropionate) Ointment Prescribing Information, 0.005%/0.064%.

   

Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension

taclonex.com

Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension Prescribing Information, 0.005%/0.064%

 

The LEO Pharma logo, LEO Pharma, and all product logos are registered trademarks of LEO Pharma A/S. ©2019 LEO Pharma Inc. All rights reserved.

September 2019. MAT-27705.